These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells. Hamilton SR, Fard SF, Paiwand FF, Tolg C, Veiseh M, Wang C, McCarthy JB, Bissell MJ, Koropatnick J, Turley EA. J Biol Chem; 2007 Jun 01; 282(22):16667-80. PubMed ID: 17392272 [Abstract] [Full Text] [Related]
10. RHAMM expression tunes the response of breast cancer cell lines to hyaluronan. Carvalho AM, Soares da Costa D, Reis RL, Pashkuleva I. Acta Biomater; 2022 Jul 01; 146():187-196. PubMed ID: 35577044 [Abstract] [Full Text] [Related]
11. Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation. Gouëffic Y, Guilluy C, Guérin P, Patra P, Pacaud P, Loirand G. Cardiovasc Res; 2006 Nov 01; 72(2):339-48. PubMed ID: 16934786 [Abstract] [Full Text] [Related]
12. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM. J Biol Chem; 2001 Sep 28; 276(39):36770-8. PubMed ID: 11448954 [Abstract] [Full Text] [Related]
13. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis. Foley JP, Lam D, Jiang H, Liao J, Cheong N, McDevitt TM, Zaman A, Wright JR, Savani RC. J Biol Chem; 2012 Oct 26; 287(44):37406-19. PubMed ID: 22948158 [Abstract] [Full Text] [Related]
20. Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury. Zaman A, Cui Z, Foley JP, Zhao H, Grimm PC, Delisser HM, Savani RC. Am J Respir Cell Mol Biol; 2005 Nov 26; 33(5):447-54. PubMed ID: 16037485 [Abstract] [Full Text] [Related] Page: [Next] [New Search]